PB-026Purity on request
CIGB-300 (P15-Tat)
C₁₂₇H₂₁₅N₅₃O₃₀S₃
Anti-CK2 cyclic cell-penetrating research peptide.
Research Use Only · Oncology Research Peptides
CAS 1072877-99-6
Docs Documentation Available Upon Request
PB-041Purity on request
Fig. · White to off-white solid powder
Oncology Research Peptides
KRAS G13D Peptide (25-mer)
C₁₁₈H₂₀₁N₂₉O₃₆S · 2634.10 g/mol
KRAS G13D Peptide (25-mer) is a synthetic neoantigen peptide derived from the G13D hotspot mutation of the human KRAS oncogene. It is studied as a research reagent for cancer-vaccine development, neoantigen-discovery research, and multi-HLA T-cell response studies, including construction of KRAS G13D-MHC tetramers for flow-cytometry-based detection of antigen-specific CD8+ T cells in immuno-oncology research.
Purity
On request
Quantity
Milligram, gram, or bulk quantities
Documentation
COA, HPLC, MS / LC-MS, SDS
Packaging
Bulk, non-branded, or private label
Research Use Only · Buyer verification required
Specifications
Technical profile.
Catalog Number
PB-041
CAS Number
145019-94-9
Sequence
Met-Thr-Glu-Tyr-Lys-Leu-Val-Val-Val-Gly-Ala-Gly-Asp-Val-Gly-Lys-Ser-Ala-Leu-Thr-Ile-Gln-Leu-Ile-Gln
Molecular Formula
C₁₁₈H₂₀₁N₂₉O₃₆S
Molecular Weight
2634.10 g/mol
Purity (HPLC)
Available specifications confirmed with quotation
Appearance
White to off-white solid powder
Vial Size
Confirmed with quotation
Storage
−20 °C, sealed, desiccated
Reconstitution
Bacteriostatic water
Classification
Research Use Only
Documentation & Quality
What documentation may be available for KRAS G13D Peptide (25-mer).
KRAS G13D Peptide (25-mer)·PB-041
Certificate of Analysis (COA)
Manufacturing partner or independent summary of identity, purity, and other release testing for a batch.
Pending Verified Documentation
HPLC Chromatogram
Chromatographic data supporting the purity result reported for a batch.
Pending Verified Documentation
Mass Spectrometry (MS) Report
Mass spectrometry data supporting molecular identity confirmation.
Pending Verified Documentation
Endotoxin Test
Endotoxin testing result, where applicable to the product and its intended use.
Pending Verified Documentation
Safety Data Sheet (SDS)
Handling, storage, and safety information for the material.
Pending Verified Documentation
Third-Party Laboratory Report
Testing performed by an independent laboratory, separate from the manufacturing partner's own QC.
Pending Verified Documentation
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Inquire about pricing and availability.
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Related compounds.
View full catalogPB-027Purity on request
Tertomotide (GV1001) Hydrochloride
C₈₅H₁₄₇ClN₂₆O₂₁
Telomerase-derived 16-mer research peptide.
Research Use Only · Oncology Research Peptides
CAS 922174-60-5
Docs Documentation Available Upon Request
PB-028Purity on request
Tigapotide (PCK-3145)
C₈₂H₁₁₉N₂₁O₃₄S₃
PSP-94-derived antitumor research peptide.
Research Use Only · Oncology Research Peptides
CAS 848084-83-3
Docs Documentation Available Upon Request